Publications
- Pilot study on microRNAs as biomarkers of response to sunitinib treatment in patients with metastatic renal cell carcinoma2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Percutaneous CT-guided Biopsy of Focal Liver Lesions-Long-term Experience with more than 300 Procedures2023 | Faculty of Medicine in Hradec Králové, Faculty of Education
- Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Combination of nivolumab and relatlimab – a new option in the treatment of malignant melanoma2023 | Faculty of Medicine in Hradec Králové
Loading network view...